Categories Technology

Ali Health’s surprise stock recovery raises eyebrows

A week earlier, many analysts were scratching their heads on why a small unit of Alibaba (BABA) became a top stock performer. By May 17, Alibaba Health Information Technology had soared at least 56% in six days, making it one of the healthiest stocks in the world. But then, last Tuesday, the unit announced a $1.4 billion deal to acquire a part of the health-based assets of its parent, the e-commerce giant – raising many eyebrows.

When news of the deal officially broke, the Alibaba unit saw its stock rise 3.8% to about HK$ 7 per share. The deal is also expected to boost Ali Health further, with more pharma-related business flowing back to it from its parent, Alibaba. According to the terms of the deal, Alibaba will have about 67% voting rights in Ali Health.

Ali Health sees stock surge a week before major deal

 

Last week, Alibaba Health announced a $1.4-billion deal to acquire pharma assets of its parent, Alibaba Group

The unit was operating at a loss a year ago but did a turnaround so swiftly that it became a top gun of the MSCI Asia Pacific Index. However, this has also made many investors approach the stock with some apprehension and caution.

Alibaba units other than Ali Health also saw quick jumps, with Alibaba Pictures recording a 32% hike last Thursday in the Honk Kong exchange.

According to many reports, no regulators have yet come out with any official announcements regarding the unusual stock surge. So it could also be that the stock grew organically due to the fact that it is, indeed, part of Jack Ma’s ever-growing empire.

Ali Health sees yearly high on deal with parent Alibaba

Most Popular

V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results

Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew

Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results

Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter

McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings

Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top